Weekly signal · NTRA · Healthcare

Natera Inc (NTRA) weekly advance accelerates with a 72.8% 12-week climb

The diagnostics stock closed at 322.10 USD as its weekly setup stayed active, with turnover running above its recent average.

Natera Inc
Latest322.10 USD
1W move20.3%
Volume1.3x
TrendActive
Molecular diagnostics lab equipment beside a market-data screen representing Natera Inc weekly stock trading.

Market update

What happened

Natera Inc (NTRA) rose 20.3% in the latest weekly reading, closing at 322.10 USD for the week ended Aug. 7. The move extended its four-week gain to 19.3% and kept the 52-week weekly price path tilted sharply higher.

Confirmation is constructive but not one-sided. The trend signal is active and Market Dynamics show positive pressure at 1.18, while Relative Strength at 32.9 remains a softer check on the move. Weekly volume reached 9.19 million shares, about 1.3x the 13-week average.

Continue your research

Explore NTRA across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

NTRA coverage

Evidence context